Pharmaceutical stocks can be excellent defensive investments during times of economic uncertainty, and many pharma stocks are ...

Incyte and TG Therapeutics are seeing strong share growth, backed up by booming revenue and earnings.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

On July 6, BioPharma Dive reported that drug developers producing new medicines for the treatment of autoimmune disorders and ...

Pharma Stocks to Buy: Pharma stocks remain in focus as analysts see upside in select large- and mid-cap names. Glenmark tops ...

Macquarie have chosen four pharma stocks that can provide up to 30 per cent returns. The analysts have given outperform ...

Choosing between Novartis AG (NYSE:NVS) and Teva Pharmaceutical Industries (NYSE:TEVA) requires weighing the stability of an established innovator against the potential of a generic specialist ...

BioAge Labs, Inc. (NASDAQ:BIOA) is one of the best low-priced pharma stocks on this list. TheFly reported on June 16 that BIOA announced the dosing of the first participant in QUELL-CV, a Phase 2 ...

Biotechnology companies are coming out of a dark period for the industry. Why has the tide turned and is now a good time to ...

Looking for the latest stock opportunities in August 2026? We have you covered. Click to read our top stock picks to consider ...

Incyte (NASDAQ: INCY) and TG Therapeutics (NASDAQ: TGTX) are commercial-stage biotech companies that are using blockbuster drugs to fund the growth of their promising pipelines. Incyte is known for ...